Piracetam, the prototype of the so-called “nootropic” drugs is used in many countries to treat cognitive impairment in aging, brain injuries, as well as dementia (Muller et al., 1999; Winblad, 2005). A recent meta-analysis of all available (published and not published) clinical studies provided compelling evidence for the global efficacy of piracetam in a diverse group of older subjects with cognitive impairment (Waegemans et al., 2002).